FDA-RFQ- BioProfile FLEX2 Parts and Components-Brand Name or Equal
The Center for Drug Evaluation and Research (CDER) requires a single contractor to supply parts and consumables compatible with three existing Nova BioProfile FLEX2 instruments at the FDA facility in Silver Spring, MD. All items must be new, unused, and fully compatible without instrument modification, with at least 75-80% shelf life remaining upon delivery. The contractor must be the manufacturer or an authorized reseller, and cold chain or flammable items must be shipped per manufacturer and DOT/IATA regulations. The period of performance is 12 consecutive months starting from the date of award. No specific budget amount is mentioned in the description.